4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-16-036187
$NBYCIK 0001389545operating
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 1:18 PM ET
Size
6.8 KB
Accession
0001437749-16-036187
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2016-08-01$1.91/sh+261,780$500,000→ 715,498 total - Award
Warrant
2016-08-01+130,890→ 273,447 totalExercise: $1.91From: 2016-08-02Exp: 2026-08-02→ Common Stock (130,890 underlying)
Footnotes (2)
- [F1]Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate 2,094,241 shares on July 31, 2016.
- [F2]Warrant acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate 1,047,121 warrants on July 31, 2016.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 1:18 PM ET
- Size
- 6.8 KB